CClinicalTrials.gg
Status unknownNCT05683613Updated Jan 13, 2023

Watering of the Eyes Following Uneventful Phacoemulsification Cataract Surgery

An observational study in Watery Eyes, sponsored by Sohag University. Status unknown. Open to participants aged 50 Years to 80 Years. Per ClinicalTrials.gov, last updated 2023-01-13.

Sponsored by Sohag University · Observational

The sponsor has not verified this record recently (last verified Jan 2023), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
50
Ages
50 Years to 80 Years
Sex
All
01

Study summary

An observational study aiming to assess the incidence and possible causes of post phacoemulsification watery eye.

Read the detailed description

This study will be conducted on patients who will undergo cataract extraction at Sohag university hospitals to evaluate the incidence of watery eyes in patients after phacoemulsification by one week , one month and three month.

  • Study Design: observational study.
  • Inclusion Criteria:

Patients with age-related cataract.

  • Exclusion Criteria:

    1. patients with watering of eyes or ocular surface diseases or watering of the eyes .
    2. patients with previous ocular surgeries.
    3. patients with glaucoma, uveitis, corneal or retinal pathologies.
  • Preoperative Evaluation:

Each patient will be subjected to the following:

Detailed history taking and full ophthalmological examination. Fluorescein dye disappearance test. Syringing and probing. Schirmer's test. Tear break up time test. Measurement of punctal diameter by AS-OCT.

  • Operative procedures:

    1. regional anesthesia.
    2. phaco technique : stop and shop.
    3. cumulative dissipated energy (CDE ) \&fluid flow.
  • Follow-up regimen: will be as follows:

    1. patients will be examined after surgery on: 1st postoperative week, 1st month, 3rd month.
    2. The following will be recorded for each patient:

      1. symptoms of watery eyes, visual acuity, IOP, slit lamp examination.
      2. dye disappearance test.
      3. Schirmer's test.
      4. tear break up time test.
      5. anterior segment OCT.
02

Conditions studied

  • Watery Eyes

Browse trials for

03

In context

Cataract

1,701 studies on the registry are indexed under Cataract; 230 are open to participants now.

This study's planned enrollment of 50 is below the median of 81 across 484 observational studies indexed under Cataract.

Browse Cataract studies →

Lead sponsor

Sohag University is the lead sponsor of 1,183 studies on the registry; 612 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

50_ 80 year old Patients with age related cataract with no watery eyes subjected for phacoemulsification cataract surgery

Inclusion criteria

  • patients with age related cataract.

Exclusion criteria

Exclusion Criteria:

  • patients with watering of the eyes or ocular surface disease.

    • patients with previous ocular surgeries .
    • patients with glaucoma, uveitis, cornealor retinal pathologies.
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
50 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Assess the incidence and possible causes of post phacoemulsification watery eye.

    Patients are examined preoperatively and postoperatively by flourescein disappearance test, probing and syringing, schirmer's test,tear breakup time test and anterior segment optical coherence tomography to detect incidence and causes of post phacoemulsification watery eye.

    Time frame: Five months

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 13, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05683613
Lead sponsor
Sohag University
Responsible party
Ahmed Helmy Mahmoud (Resident doctor at ophthalmology department in sohag university hospital, Sohag University) — Principal investigator
First posted
Jan 13, 2023
Start date
Feb 1, 2023 (estimated)
Primary completion
Jun 30, 2023 (estimated)
Completion
Sep 30, 2023 (estimated)
Last update
Jan 13, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion